Image default
Business Projects

Bio-based projects to benefit from US DOE support

The U.S. Department of Energy (DOE) has announced the selection of eight projects totalling more than $5 million to conduct research and development needed to accelerate the US biomanufacturing sector.

Part of the Agile BioFoundry (ABF) consortium, these projects will leverage National Laboratory capabilities to address challenges in biomanufacturing.

DOE has selected the following biotechnology projects:

  • C16 Biosciences will work with Pacific Northwest and Sandia National Laboratories to engineer fatty acid synthesis in Rhodosporidium toruloidesto produce sustainable replacements for palm oil.
  • Clemson University, of Clemson, SC, will address common challenges in the reliability of industrial yeast fermentation, important for a wide range of products.
  • LanzaTech, of Skokie, IL, will advance the field of synthetic biology by building solutions to more efficiently and quickly engineer production hosts at a reduced cost.
  • White Dog Labs will elucidate the specific changes microbes undergo during the continuous, cell-retention process, using the isopropanol-producing strain, Clostridium ljungdahlii, as a model system.
  • Kalion will use machine learning and artificial intelligence to lower growth media production costs, increase productivity, and increase the overall commercial feasibility of biomanufacturing, with glucaric acid production as their model.
  • Danimer Scientific will use ABF’s Learn tools and systems’ biology capabilities to produce tunable combinations of polyhydroxyalkanoates with different chain lengths, enabling new biodegradable plastics with novel properties.
  • Invaio will develop an efficient bioprocess for the industrial production of an antimicrobial peptide, which could prove revolutionary for agriculture and add to ABF’s core capabilities.
  • Enduro Genetics will use its “product addiction” technology in industrial host organisms to demonstrate its ability to agnostically improve product titer, rate, and yield.

Each of the ABF Directed Funding Opportunity awardees will be invited to collaborate with National Lab research facilities to conduct their proposed research. Seed awards provide up to $500,000 in DOE funds to the labs for up to two years.

Full awards are up to $2,000,000 and three years. This assistance by the National Laboratories will aim to develop novel microbial hosts and bioproducts, use cutting-edge artificial intelligence and machine learning in synthetic biology, and address the problem of production heterogeneity in industrial microbiology. Each of the awardees has committed to a minimum 20% cost-share contribution.

Sponsored by the DOE Office of Energy Efficiency and Renewable Energy’s Bioenergy Technologies Office, the ABF aims to advance biomanufacturing by uniting and expanding the capabilities of the National Laboratories to develop a robust, agile biomanufacturing platform accessible to researchers across the private and public sectors.

ABF partners include Argonne National Laboratory, Lawrence Berkeley National Laboratory, Los Alamos National Laboratory, Oak Ridge National Laboratory, Pacific Northwest National Laboratory, Sandia National Laboratories, the National Renewable Energy Laboratory, and more than a dozen university and industry partners.


If you were interested in this synthetic biology story, you may also be interested in the ones below.

Read: 5 Minutes With… Shara Ticku from C16 Biosciences.

Read:  5 Minutes With…Jay Fitzgerald from U.S. Department of Energy’s Bioenergy Technologies Office.

Read: 5 Minutes With…Marco Mirata from Lonza.

Read: 5 Minutes With…Kate Krueger from New Harvest.

Read: 5 Minutes With…. Daan Luining from Meatable.

Read: 5 Minutes With… Alexander Lorestani from Geltor.

Read: 5 Minutes With… Joško Bobanović from Sofinnova Partners.

Related posts

How the ButaNexT project is helping realise the dream of cost-competitive biobutanol.

Luke Upton

5 Minutes With… Rolf Hogan from RSB.

Liz Gyekye

BIC links up with CoR to launch new bio-based investment platform

Liz Gyekye

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More